Results 121 to 130 of about 25,034,870 (238)
Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis [PDF]
Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approximately 50% of neurofibromatosis type 1 (NF1) patients.
Chen, Shi +8 more
core +1 more source
Background: Neurofibromatosis type I (NF1) is caused by heterozygous loss-of-function variants in the NF1 gene encoding neurofibromin which serves as a tumor suppressor that inhibits RAS signaling and regulates cell proliferation and differentiation ...
Ofer Isakov +3 more
doaj +1 more source
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas [PDF]
Plexiform neurofibromas (pNF) are pathognomonic nerve and soft tissue tumors of neurofibromatosis type I (NF1), which are highly resistant to conventional chemotherapy and associated with significant morbidity/mortality.
Chen, Shi +13 more
core +1 more source
NF2 regulates IP3R‐mediated Ca2+ signal and apoptosis in meningiomas
Meningiomas are the most common primary intracranial tumors and account for nearly 30% of all nervous system tumors. Approximately half of meningioma patients exhibit neurofibromin 2 (NF2) gene inactivation.
Zhaoying Lei +12 more
semanticscholar +1 more source
Reproducibility of cognitive endpoints in clinical trials: Lessons from neurofibromatosis type 1 [PDF]
OBJECTIVE: Rapid developments in understanding the molecular mechanisms underlying cognitive deficits in neurodevelopmental disorders have increased expectations for targeted, mechanism-based treatments.
et al, +2 more
core +1 more source
Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2
Neurofibromatosis Type 2 (NF-2) is a dominantly inherited genetic disorder that results from mutations in the tumor suppressor gene, neurofibromin 2 (NF2) gene.
Ayyappa Raja Desingu Rajan +7 more
semanticscholar +1 more source
Targeting meningiomas: advances in molecular pathways, drug repurposing, and precision therapy
Background Meningiomas are the most common primary intracranial tumors in adults, accounting for more than one-third of brain neoplasms. Most are slow-growing, but higher-grade subtypes (WHO grades II–III) often recur, invade surrounding structures, and ...
Mohammed A. Abdel-Rasol +1 more
doaj +1 more source
Sensorineural hearing loss (SNHL) is a hallmark symptom in patients with neurofibromatosis type 2-associated schwannomatosis (NF2-SWN), a genetic condition caused by mutations in the Neurofibromin II gene that encodes the tumor suppressor protein Moesin ...
Reef K. Al-Asad +12 more
doaj +1 more source
Characteristics of MAX-negative and MAX-positive GIST cases. Selected molecular, demographic, and clinical characteristics of GIST sample sets stratified by MAX immunohistochemical expression. (DOC 60 kb)
Belinsky, Martin +7 more
openaire +1 more source
Cranial neural crest cells (CNCs) play a critical role in craniofacial bone morphogenesis, engaging in intricate interactions with various molecular signals to ensure proper development, yet the molecular scaffolds coordinating these processes remain ...
Yuping Huang +9 more
doaj +1 more source

